From: The Menopause Rating Scale (MRS) scale: A methodological review
Europe | North America | Latin America | Asia | |
---|---|---|---|---|
Total score | ||||
No, little (0–4) | 28.8 (+/-1.3) | 28.0 (+/-2.3) | 31.0 (+/-1.7) | 40.2 (+/-3.0) |
Mild (5–8) | 21.9 (+/- 1.2) | 23.9 (+/-2.2) | 20.2 (+/-1.4) | 27.5 (+/-2.8) |
Moderate (9–16) | 25.1 (+/-1.2) | 25.7 (+/-2.2) | 26.2 (+/-1.6) | 22.8 (+/-2.6) |
Severe (17+) | 24.3 (+/- 1.2) | 22.5 (+/-2.1) | 22.7 (+/-1.5) | 9.5 (+/-1.8) |
Psychological domain | ||||
No, little (0–1) | 35.4 (+/-1.4) | 36.8 (+/-2.4) | 36.8 (+/-1.6) | 41.3 (+/-3.1) |
Mild (2–3) | 21.8 (+/-1.2) | 21.9 (+/-2.1) | 21.9 (+/-1.4) | 25.4 (+/-2.7) |
Moderate (4–6) | 19.5 (+/-1.1) | 18.7 (+/-2.0) | 18.7 (+/-1.4) | 21.3 (+/-2.6) |
Severe (7+) | 23.4 (+/-1.2) | 22.5 (+/-2.1) | 22.5 (+/-1.7) | 12.0 (+/-2.0) |
Somato-vegetative domain | ||||
No, little (0–2) | 39.5 (+/-1.4) | 37.9 (+/-2.4) | 42.1 (+/-1.8) | 46.8 (+/-3.1) |
Mild (3–4) | 22.6 (+/-1.2) | 25.6 (+/-2.2) | 19.4 (+/-1.4) | 27.0 (+/-2.8) |
Moderate (5–8) | 24.2 (+/-1.2) | 24.3 (+/-2.2) | 25.6 (+/-1.6) | 20.8 (+/-2.5) |
Severe (9+) | 13.7 (+/-1.0) | 12.1 (+/-1.7) | 12.9 (+/-1.2) | 5.4 (+/-1.4) |
Urogenital domain | ||||
No, little (0) | 34.3 (+/-1.3) | 33.4 (+/-2.4) | 28.2 (+/-1.8) | 55.6 (+/-3.1) |
Mild (1) | 17.2 (+/-1.1) | 17.0 (+/-2.0) | 18.6 (+/-1.1) | 18.6 (+/-2.4) |
Moderate (2–3) | 23.0 (+/- 1.2) | 24.2 (+/-2.2) | 21.8 (+/-1.3) | 17.0 (+/-2.3) |
Severe (4+) | 25.6 (+/-1.2) | 25.4 (+/-2.2) | 31.4 (+/-1.3) | 8.8 (+/-1.8) |